220 related articles for article (PubMed ID: 26000514)
1. Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis.
Reynolds WS; McPheeters M; Blume J; Surawicz T; Worley K; Wang L; Hartmann K
Obstet Gynecol; 2015 Jun; 125(6):1423-1432. PubMed ID: 26000514
[TBL] [Abstract][Full Text] [Related]
2. Which anticholinergic drug for overactive bladder symptoms in adults.
Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
[TBL] [Abstract][Full Text] [Related]
3. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.
Nabi G; Cody JD; Ellis G; Herbison P; Hay-Smith J
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD003781. PubMed ID: 17054185
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.
Alhasso AA; McKinlay J; Patrick K; Stewart L
Cochrane Database Syst Rev; 2006 Oct; (4):CD003193. PubMed ID: 17054163
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Roxburgh C; Cook J; Dublin N
Cochrane Database Syst Rev; 2007 Jul; (3):CD003190. PubMed ID: 17636716
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Roxburgh C; Cook J; Dublin N
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003190. PubMed ID: 17943782
[TBL] [Abstract][Full Text] [Related]
8. Which anticholinergic drug for overactive bladder symptoms in adults.
Hay-Smith J; Herbison P; Ellis G; Morris A
Cochrane Database Syst Rev; 2005 Jul; (3):CD005429. PubMed ID: 16034974
[TBL] [Abstract][Full Text] [Related]
9. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
10. Trospium chloride for the treatment of overactive bladder with urge incontinence.
Singh-Franco D; Machado C; Tuteja S; Zapantis A
Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
[TBL] [Abstract][Full Text] [Related]
11. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.
Hay-Smith J; Herbison P; Ellis G; Moore K
Cochrane Database Syst Rev; 2002; (3):CD003781. PubMed ID: 12137711
[TBL] [Abstract][Full Text] [Related]
13. Treatment of overactive bladder in women.
Hartmann KE; McPheeters ML; Biller DH; Ward RM; McKoy JN; Jerome RN; Micucci SR; Meints L; Fisher JA; Scott TA; Slaughter JC; Blume JD
Evid Rep Technol Assess (Full Rep); 2009 Aug; (187):1-120, v. PubMed ID: 19947666
[TBL] [Abstract][Full Text] [Related]
14. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
Malone-Lee JG; Al-Buheissi S
BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
[TBL] [Abstract][Full Text] [Related]
15. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
[TBL] [Abstract][Full Text] [Related]
16. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program.
Meijer EF; Nieuwhof-Leppink AJ; Dekker-Vasse E; de Joode-Smink GC; de Jong TP
J Pediatr Urol; 2015 Feb; 11(1):21.e1-5. PubMed ID: 25205144
[TBL] [Abstract][Full Text] [Related]
17. Potential Primary Endpoint for Exploratory Clinical Trial in Patients with Overactive Bladder: A Systematic Literature Review.
Iino S; Kaneko M; Narukawa M
Low Urin Tract Symptoms; 2018 Jan; 10(1):64-75. PubMed ID: 27792298
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
J Urol; 2017 Feb; 197(2S):S216-S223. PubMed ID: 28012773
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of placebo effects on urinary incontinence in overactive bladder syndrome: A meta-analysis of Japanese placebo-controlled clinical trials.
Hara T
Int J Urol; 2023 Oct; 30(10):896-905. PubMed ID: 37317904
[TBL] [Abstract][Full Text] [Related]
20. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis.
Balzarro M; Rubilotta E; Mancini V; Trabacchin N; Oppezzi L; Li Marzi V; Fusco F; Serati M
Sex Med Rev; 2019 Oct; 7(4):565-574. PubMed ID: 31326358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
